Fintel reports that on April 6, 2025, REDBURN ATLANTIC downgraded their outlook for H & M Hennes & Mauritz AB (OTCPK:HMRZF) ...

Fintel reports that on April 7, 2025, Redburn Atlantic upgraded their outlook for Roku (NasdaqGS:ROKU) from Neutral to Buy. Analyst Price Forecast Suggests 81.28% Upside As of April 1, 2025, the ...

Redburn Atlantic upgraded Roku (ROKU) to Buy from Neutral with a $100 price target The firm says the company has “defensive attributes” with ...

Redburn Atlantic downgraded Qiagen (QGEN) to Neutral from Buy with a price target of EUR 41, down from EUR 47. The firm reduced the company’s ...

Research analysts at Redburn Atlantic began coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) in a ...

Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...

On Monday, Redburn-Atlantic revised its stance on QIAGEN NV (QIA:GR) (NYSE: QGEN), downgrading the company’s stock rating from Buy to Neutral and adjusting the price target from EUR47.00 to ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

On Monday, Redburn-Atlantic revised its stance on QIAGEN NV (QIA:GR) (NYSE: QGEN), downgrading the company’s stock rating from Buy to Neutral and adjusting the price target from EUR47.00 to EUR41.00.

Oil majors saw their stocks nosedive as the one-two punch of US President Donald Trump’s sweeping tariffs and OPEC+ ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (LSE:0KSX) with a Buy recommendation. As of April 2, 2025, the average one-year price target for ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Labcorp Holdings (BMV:LH) with a Buy recommendation. There are 3 funds or institutions reporting positions in Labcorp ...